BioGaia signs with Ewopharma for CE Europe
Swedish biotech BioGaia has signed a new agreement with Ewopharma to distribute its probiotic drops and tablets in a number of new markets in Central Eastern Europe.
News, Analysis & Insights on Nutrition, Supplements, and Health
Swedish biotech BioGaia has signed a new agreement with Ewopharma to distribute its probiotic drops and tablets in a number of new markets in Central Eastern Europe.
The codetermination talks Raisio began in early September have been concluded, according to a company release to the stock exchange.
French scientists, in collaboration with Nestlé Research Centre, have shown that an in vitro digestion model could be a valuable tool to quantify potential bioaccessibility of vitamin E and carotenoids from functional food.
Researchers at the University of Virginia are starting a new project, funded by the National Cancer Institute, to unlock the secrets behind broccoli's potential anti-cancer benefits.
Increasing vitamin D levels may help curb the development and progression of breast cancer, suggests a small study from Imperial College London.
A major project to boost standards in African medicinal plants and spur European trade has yielded its first results, but more support is sought to ensure its long-term survival.
Health Sciences Group is intending to acquire specialty tea and food company Kalahari - the first acquisition since its focus shift from ingredients to branded finished foods and an indication of its new, market-driven strategy.